Clinical Phenotypes and Treatment‐Response Modifiers in Chronic Painful Temporomandibular Disorders: A Systematic Review and Evidence Map

Xinqi Huang, Ma Daniella C. B. Layson, Zhihe Zhao, Xiao Cen
Journal of Oral Rehabilitation · Wiley · 2026-11-14 · DOI: 10.1111/joor.70379

Аннотация

ABSTRACT Background Treatment outcomes in painful temporomandibular disorders (TMD) vary between patients. The value of clinical characteristics for treatment selection remains unclear. Objective To identify clinical characteristics associated with treatment outcomes or differential treatment benefit in chronic painful TMD. Methods PubMed/MEDLINE, Embase, Scopus and Cochrane CENTRAL were searched through 1 May 2026. Two reviewers independently selected studies, extracted data and assessed risk of bias. Findings were synthesised narratively and presented in an evidence map. Prognostic factors, treatment‐effect modifiers, mediators, treatment responses and clinical phenotypes were considered separately. Results Nineteen reports were included. Six examined prognosis, and three tested interactions between treatment and baseline characteristics. In separate cognitive‐behavioural therapy (CBT) analyses, greater baseline masticatory limitation was associated with greater improvement in jaw function (interaction p = 0.001), whereas lower somatisation and higher self‐efficacy or readiness were associated with greater pain reduction with the addition of CBT to standard care. The third interaction analysis was not statistically significant. One secondary analysis reported indirect effects through changes in pain beliefs and self‐efficacy. Two studies identified clinical phenotypes but did not prospectively evaluate their use in treatment selection. Of the 12 randomised trial analyses assessed, eight had some concerns and four were judged to be at high risk of bias. All six prognostic analyses were judged to be at high risk of bias. Conclusion Psychosocial and functional characteristics were associated with treatment outcomes in several studies. Potential modifiers of the effects of CBT were identified, but independent validation is needed before these characteristics can guide treatment selection. PROSPERO Registration CRD420261381185

Читать у издателя →

Похожие статьи